×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
Dermopatie in pazienti in trattamento con Imatinib mesilatoeprints.bice.rm.cnr.it/4694/1/article(21).pdfIntroduzione L’Imatinib mesilato (IM) o STI 571 rappresenta il trattamento
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form